Inventor
LOWMAN HENRY BERNARD
US18 patents
Patents
18 patentsUS9127053B2Sep 8, 2015
Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof
CYTOMX THERAPEUTICS INC39 citations97
US9120853B2Sep 1, 2015
Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof
CYTOMX THERAPEUTICS INC52 citations97
US10301380B2May 28, 2019
Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof
CYTOMX THERAPEUTICS INC17 citations94
US9889211B2Feb 13, 2018
Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof
CYTOMX THERAPEUTICS INC29 citations94
US10533053B2Jan 14, 2020
Nucleic acids encoding activatable antibodies that bind epidermal growth factor receptor
CYTOMX THERAPEUTICS INC12 citations93
US9540440B2Jan 10, 2017
Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof
CYTOMX THERAPEUTICS INC31 citations93
US9545442B2Jan 17, 2017
Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof
CYTOMX THERAPEUTICS INC19 citations92
US9517276B2Dec 13, 2016
Compositions and methods for conjugating activatable antibodies
CYTOMX THERAPEUTICS INC24 citations92
US10709799B2Jul 14, 2020
Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof
CYTOMX THERAPEUTICS INC10 citations84
US9688748B2Jun 27, 2017
Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof
CYTOMX THERAPEUTICS INC11 citations84
US11180562B2Nov 23, 2021
Method of treating or delaying progression of an epidermal growth factor receptor (EGFR)-related disorder by administering activatable EGFR-binding antibodies
CYTOMX THERAPEUTICS INC5 citations83
US9856314B2Jan 2, 2018
Activatable antibodies having non-binding steric moieties and methods of using the same
CYTOMX THERAPEUTICS INC15 citations83
US11161906B2Nov 2, 2021
Multispecific antibodies, multispecific activatable antibodies and methods of using the same
CYTOMX THERAPEUTICS INC12 citations82
US11890354B2Feb 6, 2024
Activatable antibodies that bind epidermal growth factor receptor and methods thereof
CYTOMX THERAPEUTICS INC2 citations73
US12139543B2Nov 12, 2024
Method of using an anti-epidermal growth factor receptor (EGFR) activatable antibody to detect the presence or absence of a cleaving agent and EGFR
CYTOMX THERAPEUTICS INC1 citations72
US12502439B2Dec 23, 2025
Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof
CYTOMX THERAPEUTICS INC0 citations62
US10894821B2Jan 19, 2021
Activatable antibodies having non-binding steric moieties and methods of using the same
CYTOMX THERAPEUTICS INC0 citations62
US11992528B2May 28, 2024
Compositions and methods for conjugating activatable antibodies
CYTOMX THERAPEUTICS INC0 citations60